Critical Contrast: Nihon Kohden (OTCMKTS:NHNKY) versus PetVivo (NASDAQ:PETV)

PetVivo (NASDAQ:PETV) and Nihon Kohden (OTCMKTS:NHNKY) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Analyst Ratings

This is a summary of recent ratings and recommmendations for PetVivo and Nihon Kohden, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0	0	0	0	0.00
Nihon Kohden	0	1	0	1	3.00

Profitability

This table compares PetVivo and Nihon Kohden’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Nihon Kohden	5.90%	9.08%	6.37%

Institutional and Insider Ownership

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 0.1% of Nihon Kohden shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares PetVivo and Nihon Kohden”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05 million	23.58	-$10.95 million	($0.38)	-1.71
Nihon Kohden	$1.56 billion	0.98	$95.79 million	$0.59	15.47

Nihon Kohden has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Nihon Kohden, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

PetVivo has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Nihon Kohden has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.

Summary

Nihon Kohden beats PetVivo on 9 of the 13 factors compared between the two stocks.

About PetVivo

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.